文献速递临床试验与 GCP真实世界研究与卫生经济

在澳大利亚低社会经济地位人群中,雾化尼古丁产品与尼古丁替代疗法用于戒烟的有效性、安全性和成本效果:一项随机对照试验的研究方案

Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2022-09-14

本研究为在澳大利亚新南威尔士大学国家药物与酒精研究中心开展的两臂、开放标签、优效性、平行组随机对照试验,计划纳入1058名每日吸烟且有意戒烟的政府养老金或津贴领取者,1:1随机接受8周免费雾化尼古丁产品(pod装置40 mg/mL尼古丁盐和tank装置18 mg/mL游离碱尼古丁,混合口味)或尼古丁替代疗法(4 mg口香糖或含片),所有参与者接受5周每日短信行为支持;主要结局为7个月随访时经一氧化碳呼气测试≤5ppm验证的6个月持续戒断。

要点

  • 方案比较雾化尼古丁产品(pod和tank装置)与尼古丁替代疗法(口香糖或含片)的戒烟有效性、安全性和成本效果。
  • 计划纳入1058名每日吸烟且有意戒烟的政府养老金或津贴领取者,1:1随机分组。
  • 主要结局为7个月随访时经一氧化碳呼气测试≤5ppm验证的6个月持续戒断。

核心结论

  • 需要更多数据来加强雾化尼古丁产品辅助戒烟的证据确定性,尤其是新一代pod装置。
  • 据作者所知,本试验是首个提供雾化尼古丁产品选择的试验,且新型pod装置尚无比较有效性试验数据。
  • 若有效,研究结果可为在优先人群中更广泛实施雾化尼古丁产品辅助戒烟提供信息。

研究设计与样本

  • 两臂、开放标签、优效性、平行组随机对照试验,采用分配隐藏和盲法结局评估。
  • 在澳大利亚悉尼新南威尔士大学国家药物与酒精研究中心开展。
  • 计划纳入1058名每日吸烟、有意戒烟并领取政府养老金或津贴的参与者,按1:1比例随机分组。

主要发现

  • 干预组接受8周免费雾化尼古丁产品,包括pod装置(40 mg/mL尼古丁盐)和tank装置(18 mg/mL游离碱尼古丁),混合口味。
  • 对照组接受8周免费尼古丁替代疗法(口香糖或含片;4 mg)。
  • 所有参与者接受5周每日短信行为支持。
  • 主要结局为7个月随访时经一氧化碳呼气测试≤5ppm验证的6个月持续戒断,并评估安全性和成本效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更多数据来加强雾化尼古丁产品辅助戒烟的证据确定性,尤其是新一代pod装置。
  • 据作者所知,新型pod装置尚无比较有效性试验数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Australia, tobacco smoking rates have declined but inequalities remain with significantly higher smoking prevalence among low-socioeconomic populations. Clinical trial data suggest vaporized nicotine products (VNPs) aid smoking cessation. Most VNP trials have used refillable tank systems, but newer generation (pod) devices now comprise the largest market share yet have limited clinical trial evidence on safety and effectiveness. This study evaluates the effectiveness, safety and cost-effectiveness of VNPs (pod and tank device) compared with nicotine replacement therapy ([NRT]-gum or lozenge) for smoking cessation. METHODS: This is a two-arm, open-label, superiority, parallel group, randomized controlled trial (RCT) with allocation concealment and blinded outcome assessment. The RCT is conducted at the National Drug and Alcohol Research Centre at the University of New South Wales, Sydney, Australia. Participants are people who smoke daily, are interested in quitting and receive a government pension or allowance (N = 1058). Participants will be randomized (1:1 ratio) to receive 8 weeks of free: VNPs, with pod (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine) in mixed flavours; or NRT (gum or lozenge; 4 mg). All participants will receive daily text message behavioural support for 5 weeks. Assessments will be undertaken by telephone at baseline, with three follow-up calls (two check-in calls within the first month and final follow-up at 7 months post randomization) to ascertain smoking status, treatment adherence and adverse events. The primary outcome is 6-month continuous abstinence verified by carbon monoxide breath test of ≤5ppm at 7-month follow-up. Safety and cost-effectiveness of VNPs versus NRT will also be evaluated. DISCUSSION: Further data are required to strengthen certainty of evidence for VNPs aiding smoking cessation, particularly for newer generation pod devices. To our knowledge, this trial is the first to offer choice of VNPs and no comparative effectiveness trial data exists for new pod devices. If effective, the findings can inform wider implementation of VNPs to aid smoking cessation in a priority group. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12621000076875. Registered on 29 January 2021. https://www.anzctr.org.au.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Howard BC, McRobbie H, Petrie D, et al. Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial. Trials. 2022. PMID: 36104702. doi:10.1186/s13063-022-06644-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。